bioAffinity furnishes presentation slides for H.C. Wainwright conference; no figures in 8-K body

bioAffinity Technologies, Inc.

Presentation materials (Exhibit 99.1) cover operations and performance; specifics only in the exhibit.
Materials to be used at H.C. Wainwright 28th Annual Global Investment Conference, Sept 14-16, 2026.
Report signed by President/CEO Maria Zannes; no financial or operational data disclosed in body.
Common stock (BIAF) and warrants (BIAFW) trade on Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.